Jun S. Wei
Jun S. Wei
National Cancer Institute, National Institutes of Health
Verified email at - Homepage
Cited by
Cited by
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
J Khan, JS Wei, M Ringner, LH Saal, M Ladanyi, F Westermann, ...
Nature medicine 7 (6), 673-679, 2001
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ...
Nature genetics 45 (3), 279-284, 2013
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ...
Cancer discovery 4 (2), 216-231, 2014
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ...
Nature genetics 47 (8), 864-871, 2015
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, ...
PLoS genetics 10 (7), e1004475, 2014
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
JGT Vi, AT Cheuk, PS Tsang, JY Chung, YK Song, K Desai, Y Yu, ...
The Journal of clinical investigation 119 (11), 3395-3407, 2009
The MYCN oncogene is a direct target of miR-34a
JS Wei, YK Song, S Durinck, QR Chen, ATC Cheuk, P Tsang, Q Zhang, ...
Oncogene 27 (39), 5204-5213, 2008
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
DA Oldridge, AC Wood, N Weichert-Leahey, I Crimmins, R Sussman, ...
Nature 528 (7582), 418-421, 2015
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
JS Wei, BT Greer, F Westermann, SM Steinberg, CG Son, QR Chen, ...
Cancer research 64 (19), 6883-6891, 2004
PAX3–FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability
BE Gryder, ME Yohe, HC Chou, X Zhang, J Marques, M Wachtel, ...
Cancer Discovery 7 (8), 884-899, 2017
Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis
L Mariani, C Beaudry, WS McDonough, DB Hoelzinger, T Demuth, ...
Journal of neuro-oncology 53, 161-176, 2001
EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
C Wang, Z Liu, CW Woo, Z Li, L Wang, JS Wei, VE Marquez, SE Bates, ...
Cancer research 72 (1), 315-324, 2012
Apparatus for microarray binding sensors having biological probe materials using carbon nanotube transistors
RDR Gomez, J Khan, H Pandana, K Aschenbach, M Fuhrer, JS Wei
US Patent 8,017,938, 2011
Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity
J Lu, TE Landerholm, JS Wei, XR Dong, SP Wu, X Liu, K Nagata, ...
Developmental biology 240 (2), 404-418, 2001
Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma
KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ...
Cancer cell 32 (3), 295-309. e12, 2017
Database of mRNA gene expression profiles of multiple human organs
CG Son, S Bilke, S Davis, BT Greer, JS Wei, CC Whiteford, QR Chen, ...
Genome research 15 (3), 443-450, 2005
CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus
MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ...
Cancer research 75 (15), 3155-3166, 2015
Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers
RJ Orentas, JJ Yang, X Wen, JS Wei, CL Mackall, J Khan
Frontiers in oncology 2, 194, 2012
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
R Hassan, B Morrow, A Thomas, T Walsh, MK Lee, S Gulsuner, ...
Proceedings of the National Academy of Sciences 116 (18), 9008-9013, 2019
Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma
P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ...
Cancer discovery 8 (5), 582-599, 2018
The system can't perform the operation now. Try again later.
Articles 1–20